Prime Medicine, Inc. SEC filings PRME
Prime Medicine, Inc. has 298 filings in SEC EDGAR's recent list, going back to Dec 20, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Other events
|
Jul 8, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 5, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 31, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
May 19, 2025 | May 16, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 30, 2024 | Sep 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 21, 2024 | May 17, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2023 | May 17, 2023 |
| 8-K |
Current report
Officer or director change
|
May 11, 2023 | May 10, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K/A |
Amended current report
Results of operations
|
Mar 10, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 24, 2022 | Oct 19, 2022 |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PRME (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1894562
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.